CannabisNewsBreaks Archive - Page 78 of 217

WednesdayJun 24, 2020 11:04 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) to Hold AGM in December 2020

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced plans for its Annual General Meeting ("AGM"). According to the update, due to ongoing concerns related to the 2019 novel coronavirus ("COVID-19") and in order to provide its shareholders with the opportunity to have an in-person meeting, the Company has decided to hold its AGM on December 15, 2020. "Holding our AGM in December increases the likelihood of being able to have an in-person format, which is preferred, while we will continue to provide regular business updates reflecting our scaled operations to…

WednesdayJun 24, 2020 10:32 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Enters Supply and Clinic Services Agreements with Medical Cannabis by Shoppers(TM)

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) and its subsidiaries have entered into both a product supply agreement and a clinic services agreement with Medical Cannabis by Shoppers(TM). Under the supply agreement, VIVO’s licensed producers will offer a broad portfolio of Canna Farms(TM) and Beacon Medical(TM) branded medical cannabis products through the Medical Cannabis by Shoppers(TM) online sales platform, accessible to patients across Canada. "We have a six-year track record of cultivating and producing high-quality, medical-grade cannabis and are thrilled to partner with Shoppers Drug Mart Inc." Barry Fishman, CEO of VIVO, said in the news release. "VIVO is extremely committed…

WednesdayJun 24, 2020 10:08 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Results from 2020 Annual and Special Meeting

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced the results of the 2020 Annual and Special Meeting (the "Meeting"). According to the update, the Meeting was held at 1:00 p.m. (Pacific Time) on June 23, 2020, whereby there were 47,819,789 shares of the Company represented in person or by proxy, constituting 53.38% of the Company's issued share capital as at May 13, 2020, being the record date of the Meeting. All of the proposals are described in detail in the Company's proxy statement filed with the Securities Exchange Commission via Edgar and…

TuesdayJun 23, 2020 10:41 am

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Appoints New SVP to Lead Sales and Marketing of New Line of Cannabinoids

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF) on Monday announced that Christopher Speed has joined the Company as Senior Vice President, Sales and Marketing, effective July 1, 2020. In this role, Speed will be responsible for leading the sales and marketing of Willow's new line of cannabinoids, along with the Company's strategic planning and customer initiatives. “We are very excited to have Chris join our team,” Trevor Peters, president and CEO of Willow, stated in the news release. “His expertise and experience in sales and marketing along with his strong background in the ingredients space with consumer packaged goods will be…

TuesdayJun 23, 2020 10:05 am

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Most Recent Addition to Portfolio of Disruptive Cannabis Companies Receives Health Canada License

Canopy Rivers (TSX: RIV) (OTC: CNPOF) on Monday announced that the most recent addition to its portfolio of disruptive cannabis companies, Dynaleo Inc., has received its Standard Processing License from Health Canada. According to the update, this follows the completion and commissioning of Dynaleo's 27,000 square foot purpose-built facility and is a key milestone as it aims to ramp up production of white label gummies for the Canadian recreational market. "We are thrilled with the momentum at Dynaleo," Narbé Alexandrian, president and CEO of Canopy Rivers, stated in the news release. "Data shows that the total addressable market for edibles,…

MondayJun 22, 2020 11:42 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Regulatory Review

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”). The review relates to Champignon’s disclosure obligations since it became a reporting issuer on February 6, 2020 and includes a review of the disclosure surrounding certain recent acquisitions completed by the Company. “With the recent growth and interest in our industry, ensuring our disclosure obligations are satisfied is at the forefront of our attention. Ensuring fulsome and timely disclosure…

MondayJun 22, 2020 10:20 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Expansion of Cultivation and Processing Capacity

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its wholly-owned subsidiary, Canna Farms Limited, has received all necessary Health Canada approvals to commence operations in its Phase 5 expansion, and that its wholly-owned subsidiary, ABcann Medicinals Inc. ("NCC"), has begun commercial production in its ethanol extraction suite. According to the update, the Phase 5 expansion of the Hope, British Columbia facility consists of 10,000 square feet of production space customized to incorporate Canna Farms' two-tier growing systems, as well as vegetative, mother and processing rooms and storage vaults. "Health Canada's approval of Phase 5 is a major milestone for…

FridayJun 19, 2020 12:54 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Reports Encouraging Q1 2020 Financial, Operational Results

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, recently reported unaudited financial and operational results for Q1 2020 (http://cnw.fm/7raXQ). An article discussing the company further reads, “‘Our first-quarter financial results paint the picture of a much healthier business than previous quarters,’ he continued. ‘But the work is far from done. In 2020, we are focused on leveraging our core capabilities to create capital-efficient growth through known distribution channels.’ . . . According to the report filed with the Canadian Securities Exchange (‘CSE’), net revenues for the company rose from $3.2 million for…

FridayJun 19, 2020 12:19 pm

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Partners with Medipharm Labs to Leverage GMP Production Capabilities, Accelerate Australian Market Presence

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its subsidiary, Beacon Medical Australia Pty. Ltd. ("Beacon Medical Australia"), entered into an agreement with MediPharm Labs Australia Pty. Ltd. ("MediPharm Labs Australia"), a subsidiary of MediPharm Labs Corp. (TSX: LABS) ("MediPharm Labs"). Under the agreement, MediPharm Labs Australia will supply pharmaceutical-quality (GMP certified), formulated cannabis oil products to Beacon Medical Australia to sell into the Australian market. "VIVO's international efforts remain focused on the emerging Australian and German markets and we continue to seek out partnerships with organizations that have proven track records," Barry Fishman, CEO of VIVO, said in…

FridayJun 19, 2020 10:20 am

CannabisNewsBreaks – Champignon Brands Inc.’s (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Dr. McIntyre / CRTCE Published in Two Peer Reviewed Study Journals

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (“MDD”) while demonstrating rapid onset efficacy and safety of its treatment processes. To this accord, the Company today announced that its Chief Executive Officer, Dr. Roger McIntyre, and the Canadian Rapid Treatment Centre of Excellence (the “CRTCE”) have been recently published in two peer reviewed study journals (the “Peer Reviewed Studies”) focusing on ketamine’s safety, tolerability and effectiveness. “The publications of data as it relates…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000

CannabisNewsBreaks